IGF1R反义非编码RNA在肝癌中的差异化表达

doi:10.3969/j.issn.1004-583X.2021.07.009

临床荟萃 ›› 2021, Vol. 36 ›› Issue (7): 620-622.doi: 10.3969/j.issn.1004-583X.2021.07.009

IGF1R反义非编码RNA在肝癌中的差异化表达

谢志海¹, 周志聪¹, 桂元², 孙静锋³()

1.广州市老人院老年病治疗中心, 广州 510000
2.江苏省肿瘤医院肝胆胰外科, 南京 210013
3.南京医科大学第四附属医院肿瘤外科, 南京 210013

收稿日期:2021-01-26 出版日期:2021-07-20 发布日期:2021-08-02
通讯作者: 孙静锋 E-mail:80259801@qq.com
基金资助:
中国肝炎防治基金会天晴肝病研究基金——IRAIN在肝癌演进中的作用(TQGB20200002)

Differential expression of IGF1R antisense noncoding RNA in hepatocellular carcinoma

Xie Zhihai¹, Zhou Zhicong¹, Gui Yuan², Sun Jingfeng³()

1. Geriatric Disease Treatment Center of Guangzhou Nursing Home, Guangzhou 510000, China
2. Department of Hepatobiliary and Pancreatic Surgery, Jiangsu Cancer Hospital, Nanjing 210013, China
3. Department of Oncology, the Fourth Affiliated Hospital of Nanjing Medical University, Nanjing 210013, China

Received:2021-01-26 Online:2021-07-20 Published:2021-08-02
Contact: Sun Jingfeng E-mail:80259801@qq.com

摘要/Abstract

摘要：

目的检测胰岛素样生长因子1受体(IGF1R)反义非编码RNA(IGF1RAIN RNA)在肝癌及正常肝组织中的差异,验证其作为肝癌特征性标记物的可能。方法逆转录聚合酶链反应(RT-PCR)法检测IGF1RAIN RNA在30例肝癌癌瘤组织、癌旁组织以及16例肝血管瘤及肝囊肿术后切缘旁正常肝组织中的表达;结合患者临床及病理资料,分析其含量和肝癌的关系。结果肝癌癌瘤中IGF1RAIN RNA含量明显比癌旁及正常肝组织低(P<0.05);不同癌瘤大小、癌瘤分化程度以及肝癌肿瘤病理学分期患者IGF1RAIN RNA表达存在差异(P<0.05)。结论 IGF1RAIN RNA的含量在肝癌的明显降低,它可能是一种肝癌早期诊断的标记物。

关键词: 肝肿瘤, 生长调节素类, 逆转录聚合酶链反应, RNA

Abstract:

Objective To detect the difference of insulin-like growth factor 1 receptor(IGF1R) antisense noncoding RNA(IGF1RAIN RNA) content between hepatocellular carcinoma and normal hepatic tissues, and to verify its possibility as a characteristic marker of hepatocellular carcinoma.Methods Reverse transcriptase polymerase chain reaction(RT-PCR) was used to detect the expression of IGF1RAIN RNA in 30 cases of hepatocellular carcinoma tissues, adjacent tissues and 16 cases of normal hepatic tissues(adjacent to the resection margin of hepatic hemangioma and hepatic cyst). Combined with the clinical and pathological data, the relationship between the content and hepatocellular cancer was analyzed.Results The content of IGF1RAIN RNA was significantly lower in hepatocellular cancer than that in normal hepatic tissues and adjacent tissues (P<0.05); IGF1RAIN RNA was different in tumor size, tumor differentiation and pathological stage(P<0.05).Conclusion The content of IGF1RAIN RNA was significantly decreased in hepatocellular cancer. It may be a marker for early diagnosis of hepatocellular cancer.

Key words: liver neoplasms, somatomedins, reverse transcriptase polymerase chain reaction, RNA

中图分类号:

R735.7

谢志海, 周志聪, 桂元, 孙静锋. IGF1R反义非编码RNA在肝癌中的差异化表达[J]. 临床荟萃, 2021, 36(7): 620-622.

Xie Zhihai, Zhou Zhicong, Gui Yuan, Sun Jingfeng. Differential expression of IGF1R antisense noncoding RNA in hepatocellular carcinoma[J]. Clinical Focus, 2021, 36(7): 620-622.

导出引用管理器 EndNote|Ris|BibTeX

链接本文: https://huicui.hebmu.edu.cn/CN/10.3969/j.issn.1004-583X.2021.07.009

https://huicui.hebmu.edu.cn/CN/Y2021/V36/I7/620

图/表 2

参考文献 16

[1]	方文敏, 周绪红, 杨双, 等. 肝癌HepG2细胞株胰岛素样生长因子1和表皮生长因子受体基因沉默后放疗增敏机制[J]. 解剖学杂志, 2012,35(3):309-313, 340.
[2]	孙京男. IGF1R相关长链非编码RNA-IGF1RNA在恶性肿瘤中的作用及机制研究[D]. 吉林大学, 2014.
[3]	Perez DS, Hoage TR, Pritchett JR, et al. Long,abundantly expressed non-coding transcripts are altered in cancer[J]. Hum Mol Genet, 2008,17(5):642-655. doi: 10.1093/hmg/ddm336 URL
[4]	Sun J, Li W, Sun Y, et al. A novel antisense long noncoding RNA within the IGFlR gene locus is imprinted in hematopoietic malignancies[J]. Nucleic Acids Res, 2014,42(15):9588-9601. doi: 10.1093/nar/gku549 URL
[5]	Kang L, Sun J, Wen X, et al. Aberrant allele-switch imprinting of a novel IGFl R intragenic antisense non-coding RNA in breast cancers[J]. Eur J Cancer, 2015,51(2):260-270. doi: 10.1016/j.ejca.2014.10.031 URL
[6]	张立, 王炜, 李孝斌, 等. ARID2在原发性肝癌中的表达及对细胞增殖与细胞周期的影响[J]. 山西医科大学学报, 2018,(2):103-107.
[7]	Hakuno F, Takahashi SI, Bikle DD, et al. IGF1 receptor signaling pathways[J]. J Mol Endocrinol, 2018,61(1):T69-T86. doi: 10.1530/JME-17-0311 URL
[8]	Wang H, Tang C, Na M, et al. miR-422a inhibits glioma proliferation and invasion by targeting IGF1 and IGF1R[J]. Oncol Res, 2017,25(2):187-194. doi: 10.3727/096504016X14732772150389 URL
[9]	Xu G, Chen W, Xie W, et al. The association between IGF1 gene 3'-UTR polymorphisms and cancer risk: a meta-analysis[J]. Medicine (Baltimore), 2018,97(51):e13829. doi: 10.1097/MD.0000000000013829 URL
[10]	Yang J, Liu L, Tao H, et al. MeCP2 silencing of LncRNA H19 controls hepatic stellate cell proliferation by targeting IGF1R[J]. Toxicology, 2016, 359-360:39-46. doi: 10.1016/j.tox.2016.06.016 URL
[11]	Lian Y, Wang J, Feng J, et al. Long non-coding RNA IGF1RNA suppresses apoptosis and promotes proliferation by binding to LSD1 and EZH2 in pancreatic cancer[J]. Tumour Biol, 2016,37(11):14929-14937. doi: 10.1007/s13277-016-5380-8 URL
[12]	Refaee Saeedi N, Aghamohammadian Sharbaf H, Asghari Ebrahimabad MJ, et al. Psychological consequences of breast cancer in Iran: a meta-analysis[J]. Iran J Public Health, 2019,48(5):816-824.
[13]	Pashaiefar H, Izadifard M, Yaghmaie M, et al. Low expression of long noncoding RNA IRAIN is associated with poor prognosis in non-M3 acute myeloid leukemia patients[J]. Genet Test Mol Biomarkers, 2018,22(5):288-294. doi: 10.1089/gtmb.2017.0281 URL
[14]	Vaquero J, Lobe C, Tahraoui S, et al. The IGF2/IR/IGF1R pathway in tumor cells and myofibroblasts mediates resistance to EGFR inhibition in cholangiocarcinoma[J]. Clin Cancer Res, 2018,24(17):4282-4296. doi: 10.1158/1078-0432.CCR-17-3725 pmid: 29716918
[15]	Werner H, Sarfstein R, Bruchim I. Investigational IGF1R inhibitors in early stage clinical trials for cancer therapy[J]. Expert Opin Investig Drugs, 2019,28(12):1101-1112. doi: 10.1080/13543784.2019.1694660 URL
[16]	De Giovanni C, Landuzzi L, Palladini A, et al. Cancer vaccines co-targeting HER2/Neu and IGF1R[J]. Cancers (Basel), 2019,11(4):517. doi: 10.3390/cancers11040517 URL

标本	例数	IGF1RNA含量
正常肝组织	16	4.49±2.06
癌旁组织	30	3.71±1.89^*
肝癌组织	30	2.01±0.92^*#
F值		14.637
P值		<0.01

标本	例数	IGF1RNA含量
正常肝组织	16	4.49±2.06
癌旁组织	30	3.71±1.89^*
肝癌组织	30	2.01±0.92^*#
F值		14.637
P值		<0.01

项目	例数	IGF1RNA含量	t值	P值
年龄
>65岁 <65岁	16 14	2.41±1.01 2.14±0.69	0.842	0.407
性别
男女	19 11	2.32±0.98 2.15±0.82	0.485	0.632
乙型肝炎史
有无	18 12	2.51±1.08 2.14±0.95	0.963	0.34
肿瘤大小
小肝癌大肝癌	24 6	1.79±0.61 1.21±0.53	2.130	0.004
分化程度
低分化中高分化	19 11	2.70±0.82 1.19±0.31	5.835	0.000
肿瘤分期
早期中晚期	18 12	1.81±0.72 2.93±1.03		0.003

项目	例数	IGF1RNA含量	t值	P值
年龄
>65岁 <65岁	16 14	2.41±1.01 2.14±0.69	0.842	0.407
性别
男女	19 11	2.32±0.98 2.15±0.82	0.485	0.632
乙型肝炎史
有无	18 12	2.51±1.08 2.14±0.95	0.963	0.34
肿瘤大小
小肝癌大肝癌	24 6	1.79±0.61 1.21±0.53	2.130	0.004
分化程度
低分化中高分化	19 11	2.70±0.82 1.19±0.31	5.835	0.000
肿瘤分期
早期中晚期	18 12	1.81±0.72 2.93±1.03		0.003

IGF1R反义非编码RNA在肝癌中的差异化表达

Differential expression of IGF1R antisense noncoding RNA in hepatocellular carcinoma

RichHTML

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

图/表 2

参考文献 16

相关文章 15

编辑推荐

Metrics

本文评价

[1]	李亚, 杜涛明, 邱世香, 陈超, 钟立明. 伴有抑郁症状肝癌患者脑功能连接研究[J]. 临床荟萃, 2023, 38(6): 532-536.
[2]	王壮壮, 刘彦廷, 田春雷, 任欢, 艾文兵. 长链非编码RNA在胶质瘤中的研究进展[J]. 临床荟萃, 2023, 38(11): 1053-1056.
[3]	朱卫健, 何颖, 黄慕芳, 付社竹, 王小琪, 李志新, 陈丽君, 李小亮. 沙利度胺治疗β-地中海贫血外周血miR-223-3p水平变化及临床价值[J]. 临床荟萃, 2022, 37(6): 515-518.
[4]	李亚, 邱世香, 陈超, 钟立明. 肝癌患者抑郁相关因素及其与生活质量的关系[J]. 临床荟萃, 2022, 37(6): 539-543.
[5]	吴天娇, 常璐, 李梓浩, 徐丹, 尹昌浩, 赵维纳. 微RNA在血管性认知障碍发病机制中的研究进展[J]. 临床荟萃, 2022, 37(4): 364-368.
[6]	郭小军, 孔延亮, 刘涛, 成正祥, 张睿, 樊雷. CT引导经皮射频消融术治疗肝癌分析[J]. 临床荟萃, 2021, 36(9): 807-810.
[7]	陶嘉楠, 王学红, 张宏琳. miR-146b在恶性肿瘤中的研究进展[J]. 临床荟萃, 2021, 36(8): 765-768.
[8]	胥英, 韩彩娟, 范弘, 孟泽蓉, 王小军, 刘华. 长链非编码RNA高表达与小细胞肺癌预后不良相关性的Meta分析[J]. 临床荟萃, 2021, 36(8): 685-690.
[9]	陈礼龙, 刘务朝, 司秋艳, 张建平, 程荣, 吴权. 不同剂量硫酸氢氯吡格雷对脑梗死患者血流动力学指标及血清miR-191、miR-18a水平的影响[J]. 临床荟萃, 2021, 36(7): 608-611.
[10]	尹亮, 刘德敏, 谷国强. 长链非编码RNA与冠心病相关性研究进展[J]. 临床荟萃, 2021, 36(5): 462-466.
[11]	穆孝慧, 艾丽梅. miRNA-141在弥漫大B细胞淋巴瘤中的表达及其与预后的关系[J]. 临床荟萃, 2020, 35(8): 727-731.
[12]	张青，陈婷. microRNAs调控干细胞血管向分化的研究进展[J]. 临床荟萃, 2020, 35(5): 466-471.
[13]	狄佳1a，周华1a，李旻1a，徐婷1b，赵家璧2. 肾小管上皮细胞来源包含miroRNA-21的微囊泡在心肌肥大中的作用[J]. 临床荟萃, 2020, 35(3): 245-250.
[14]	靳星, 李文祎, 马蓉. miR-16 在冠心病患者血清中表达及功能分析[J]. 临床荟萃, 2020, 35(12): 1093-1096.
[15]	潘娅1, 陈亚丽2. 长链非编码RNA与心力衰竭的最新研究及临床意义[J]. 临床荟萃, 2018, 33(9): 775-778.